,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, Anemia, Fatigue, Nausea, Pyrexia, Decreased Platelets, Diarrhea, Decreased Lymphocyte, Headache, Decreased Hemoglobin, Cough, Edema Peripheral, Decreased Lymphocytes, Decreased Absolute Neutrophil Count, Decreased Phosphorus, Neutropenia, Decreased Total White Blood Cell Count, Muscle Spasm, Upper Respiratory Tract Infection, Hypokalemia, Pneumonia, Respiratory Tract Infection, Pulmonary Embolism, Constipation, Chills, Febrile Neutropenia, Lymphopenia, Cardiac Arrest, Cardiac Failure, Cardiac Failure Congestive, Myocardial Infarction, Myocardial Ischemia, Cataract, Vision Blurred, Abdominal Pain, Abdominal Pain Upper, Dyspepsia, Toothache, Infusion Site Reaction, Multi-Organ Failure, Pain, Influenza, Sepsis, Urinary Tract Infection, Viral Infection, Dehydration, Hyperkalemia, Hyperuricemia, Hypoalbuminemia, Hyponatremia, Muscular Weakness, Myalgia, Hypoesthesia, Paresthesia, Deafness, Anxiety, Delirium, Renal Failure, Renal Failure Acute, Renal Impairment, Dysphonia, Epistaxis, Oropharyngeal Pain, Pulmonary Edema, Erythema, Hyperhidrosis, Pruritus, Deep Vein Thrombosis, Hypotension, Decreased Appetite, Hypercalcemia, Hypocalcemia, Hypokalemia, Back Pain, Arthralgia, Pain in Extremity, Muscle Spasms, Musculoskeletal Pain, Headache, Dizziness, Peripheral Neuropathies NEC, Insomnia, Epistaxis, Rash, Death"
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome (TLS), Acute Respiratory Distress Syndrome (ARDS), acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), Posterior reversible encephalopathy syndrome (PRES), Embryo-fetal Toxicity, death"
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rash, generalized rash, macular rash, maculo-papular rash, erythematous rash, pruritus, eczema, dermatitis, allergic dermatitis, photosensitivity reaction, dysgeusia, increased creatinine, prolonged QTc, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure, hospitalization for heart failure"
4,MULTAQ,warnings and precautions,"AF, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain."
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, serious adverse reactions, discontinuation due to adverse reactions, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, serious skin reactions, diarrhea, fatal colitis, CDAD, Direct Coombs' test seroconversion, anemia, drug-induced hemolytic anemia, development of drug-resistant bacteria, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic, skin erythema, pruritis, thyroid accumulation, thyroid neoplasia"
10,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, elevated cholesterol, elevated HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, elevated total bilirubin, death"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, life-threatening reaction, worsening of transaminase elevations, development of transaminase elevations, hepatotoxicity, redistribution of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
12,TAFINLAR,adverse reactions,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, urinary tract infection, renal failure, insomnia, hemorrhage including cerebral hemorrhage and gastric hemorrhage, dry skin, dermatitis acneiform, actinic keratosis, erythema, pruritus, dizziness, oropharyngeal pain, muscle spasms, pain in extremity, dehydration, QT prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, Cutaneous squamous cell carcinoma, Keratoacanthoma, Melanoma, Basal cell carcinoma, Increased incidence of cutaneous squamous cell carcinoma, New primary malignant melanomas, KRAS mutation-positive pancreatic adenocarcinoma, Recurrent NRAS mutation-positive colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Major hemorrhages, Symptomatic bleeding in a critical area or organ, Deep vein thrombosis, Pulmonary embolism, Decrease in LVEF, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Fever, Hypotension, Rigors or chills, Dehydration, Renal failure, Severe skin toxicity, Secondary infections of skin, Grade 3 hyperglycemia, Hemolytic anemia, Teratogenic effects, Embryotoxic effects, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, weight increased, breast enlargement, gynecomastia, elevated creatine kinase, confusional state."
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence/sedation, Dizziness, Suicidal thoughts or behaviors, Fatigue/asthenia, Withdrawal seizure, Tumorigenic potential, Pancreatic acinar cell adenoma, Pancreatic acinar cell carcinoma, Tumors (breast, brain, lung, adrenal, non-Hodgkin's lymphoma, endometrial carcinoma in situ), Worsened tumors (brain, breast, prostate), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan hypersensitivity, Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Eosinophilia, Death"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, stomatitis, dyspepsia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, sinusitis, renal failure, subdural hematoma, urinary tract infection, chills, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, fatal bleeding events, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, palpitations, lightheadedness, dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angioedema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, myocardial infarctions, strokes, hepatic failure, death, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, drug-induced liver injury"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, worsening psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, concomitant immunosuppressants, methotrexate, corticosteroids, sepsis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, systemic illness, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, chronic infection, recurrent infection, tuberculosis, bacterial sepsis, lymphoma, malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, worsening congestive heart failure, new onset congestive heart failure, anaphylaxis, serious allergic reactions, Hepatitis B virus reactivation, demyelinating disease, exacerbation of demyelinating disease, new onset of demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, chronic or recurrent infection, hepatosplenic T-cell lymphoma (HSTCL), acute leukemia, chronic leukemia, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, hematologic abnormalities, leukopenia, thrombocytopenia, aplastic anemia, blood dyscrasias, infection, autoantibodies, immunosuppression, death"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne."
24,KALYDECO,warnings and precautions,"elevated transaminases, ALT elevations, AST elevations, increased transaminase levels, liver function test abnormalities, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,"worsening of disease, infectious diarrhea"
27,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"irritation of eyes, mucous membranes irritation, coughing, sneezing, irritation of airway, increase in blood pressure, transient increases in blood pressure, procedural pain, acute pain, shortness of breath."
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), cutaneous vasculitis, thrombocytopenia."
30,GRANIX,warnings and precautions,"splenic rupture, acute respiratory distress syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, capillary leak syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, anaphylaxis, death"
31,COARTEM,adverse reactions,"Headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, pyrexia (children), chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, Rhinitis, Aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria (clinically significant adverse reactions and postmarketing experience), anaphylaxis, angioedema, serious skin reactions (bullous eruption), death (in the case of post-marketing experience with fatal events such as anaphylaxis)."
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased exposure to lumefantrine, decreased efficacy, decreased bile production, increased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria, death"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, Gait disturbance, Peripheral edema, Urinary tract infections, Fall, Hyponatremia, Balance disorder, Memory impairment, Nystagmus, Depression, Insomnia, Cough, Hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"suicidal behavior, suicidal ideation, suicidal thoughts, depression, worsening of depression, unusual changes in mood or behavior, serious dermatologic reactions, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia,Seizures, severe nausea/vomiting, dehydration, gait instability, injury, hypochloremia, dizziness, disturbance in gait and coordination, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, Somnolence, Fatigue, asthenia, malaise, hypersomnia, sedation, lethargy, Cognitive Dysfunction, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, Visual Changes, diplopia, blurred vision, impaired vision, increased seizure frequency, status epilepticus, liver injury, elevations in transaminases, elevated bilirubin, abnormal thyroid function tests, decreases in serum T3 and T4, death."
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, anemia, angina pectoris, atrial fibrillation, vertigo, upper abdominal pain, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, death"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, Hypocalcemia, Osteonecrosis of the jaw (ONJ), Atypical femoral fractures, Serious infections, skin infections, hospitalization, cellulitis, Dermatologic reactions, Dermatitis, rashes, eczema, Severe Bone, Joint, Muscle Pain, Suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, malabsorption syndromes, severe renal impairment, dialysis, serum parathyroid hormone (PTH) elevations, invasive dental procedures, infection, ill-fitting dentures, coagulopathy, anemia, abdominal infections, urinary tract infections, ear infections, endocarditis, incapacitating bone pain, joint pain, muscle pain, delayed fracture healing."
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, anti-blinatumomab antibodies, death"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"infections, signs or symptoms, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), life-threatening, fatal, infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, BLINCYTO discontinuation, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, treatment discontinuation, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, febrile neutropenia, loss of consciousness, Elevated Liver Enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, medication errors (including underdose and overdose), death."
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, color vision changes, Non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, angina with sexual intercourse, congestive heart failure, prolonged erection, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, priapism, sickle cell anemia, multiple myeloma, leukemia, sudden hearing loss, tinnitus, dizziness, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
42,XIAFLEX,adverse reactions,"tendon ruptures, serious injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, penile ""popping"" sensation, severe penile hematoma, death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), other serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions, pruritus, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage."
45,XEOMIN,adverse reactions,"hypersensitivity, death, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, brow ptosis, muscle disorder, elevation of eyebrow, sensation of pressure, eye disorder, blepharospasm, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, exacerbate clinical effects, smaller neck muscle mass, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, diplopia, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, swallowing difficulties, breathing difficulties, weakening of muscles, aspiration, critical loss of breathing capacity, respiratory failure, pre-existing neuromuscular disorders, amyotrophic lateral sclerosis, neuromuscular junctional disorders, clinically significant effects, severe dysphagia, respiratory compromise, persistent epithelial defect, ectropion, narrow angle glaucoma, ecchymosis, transmission of viral diseases, Creutzfeldt-Jakob disease (CJD)."
48,GILOTRIF,adverse reactions,"diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, dyspnea, fatigue, hypokalemia, pulmonary toxicity, interstitial lung disease-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, mouth ulceration, oral mucosa erosion, mucosal erosion, mucosal ulceration, aphthous stomatitis, mucosal inflammation, nail infection, nail bed infection, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, pancreatitis, death"
49,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, severe diarrhea, bullous skin disorders, exfoliative skin disorders, blistering lesions, severe bullous, life-threatening cutaneous reactions, cutaneous reactions, Interstitial Lung Disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, lung inflammation, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, liver function worsening, severe hepatic impairment, Keratitis, acute eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, fetal harm, abortions, death."
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, red blood cell transfusions, bilirubin elevations, AST increased, ALT increased, creatinine elevated, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, dehydration, decreased appetite, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, lymphocytes decreased, leukocytes decreased, hemoglobin decreased, neutrophils decreased, platelets decreased, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection site reactions, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, signs of infection, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), other malignancies, pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, marked swelling, pain, necrosis, embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"imaging errors, blood PSA levels < 2 ng/mL, poor imaging performance, allergic reactions, anaphylaxis, radiation risk, long-term cumulative radiation exposure, increased risk for cancer, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, tissue inflammation associated with false positive images, prostatic hyperplasia associated with false positive images, interference by concomitant colchicine, interference by androgen-deprivation therapeutic drugs, colchicine effect"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis, Hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergic reactions, Coagulopathy, Hyperlipidemia, Ketoacidosis, CNS events, Allergy, Hepatobiliary disorders, Pancreatic disorders, Anti-drug antibodies (ADA)."
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, irreversible glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, antibody formation, systemic hypersensitivity reactions, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR interval prolongation, First Degree Atrioventricular (AV) Block, amylase increase, lipase increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease, Macrovascular Outcomes, Medullary Thyroid Carcinoma (MTC), Acute Renal Failure, Worsening of Chronic Renal Failure, Nausea, Vomiting, Diarrhea, Dehydration, Gastrointestinal Adverse Reactions, Severe Gastroparesis, Dysphagia, Dyspnea, Persistent Hoarseness, Serum Calcitonin Elevated, Thyroid Nodules"
59,ADREVIEW,adverse reactions,"serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic, serious reactions, withdrawal signs and symptoms, serious benzyl alcohol reactions, Gasping Syndrome, hypotension, metabolic acidosis, kernicterus, death, increased radiation exposure, decreased quality of scintigraphic images, imaging errors, transient episode of hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, site inflammation, extravasation, site pruritus, site warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function, death."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, higher than recommended dosing, repeat dosing, Hypersensitivity, Anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, emergency cardiorespiratory support, acute kidney injury, fatal fibrosis, debilitating fibrosis, surgery, severe infection, injury, drug-induced kidney toxicity, chronically reduced renal function, NSF, circulatory collapse, reaction to contrast media, bronchial asthma, allergic disorders, hypersensitivity reactions, extravsasation, tissue irritation"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, decrease in hemoglobin, transfusion of packed red blood cells, bleeding at a critical site, death, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid hemorrhage, subdural hemorrhage, gastrointestinal bleeds, age-related increased incidence of major bleeding, gastrointestinal adverse reactions, gastritis-like symptoms, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, clinical myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer."
65,PRADAXA,boxed warnings,"thrombotic events, SPINAL/EPIDURAL HEMATOMA, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment, death"
66,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, blood loss, hypotension, pathological bleeding, thrombocytopenia, epidural or spinal hematoma, paralysis, neurological impairment, midline back pain, sensory and motor deficits, bowel and/or bladder dysfunction, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, hemodynamic compromise, death"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, Spinal/epidural anesthesia or puncture, hemorrhagic stroke, Intracranial bleeding, intracerebral bleeding, intraventricular bleeding, subdural bleeding, subarachnoid bleeding, Gastrointestinal bleeding, upper GI bleeding, lower GI bleeding, rectal bleeding, Fatal bleeding, intracranial major bleed, Hemorrhagic stroke, Other ICH, Gastrointestinal (GI) bleed, Non-intracranial bleeding, hypersensitivity reactions, drug hypersensitivity, skin rash, anaphylactic reactions, allergic edema, syncope, Hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, Postprocedural hemorrhage, postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, Transaminases increased, alanine aminotransferase increased, alanine aminotransferase abnormal, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, Gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, gingival bleeding, epistaxis, contusion, hematuria, rectal hemorrhage, hematoma, menorrhagia, hemoptysis, hemorrhagic anemia, hemorrhoidal hemorrhage, gastrointestinal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term paralysis, permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious bleeding, fatal bleeding, blood loss, thrombotic events, stroke, bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, death, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
71,ZERBAXA,warnings and precautions,"decreased efficacy, anaphylactic reactions, serious hypersensitivity reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, agranulocytosis leading to death, death, increased ALT values, increased AST levels, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, flushing of the upper body, urticaria, pruritus, rash, Red-Man Syndrome, abnormal liver tests, AST elevations, bilirubin elevations, mild diarrhea, fatal colitis, morbidity, mortality, development of drug-resistant bacteria"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acutely deteriorating COPD, relief of acute symptoms, excessive use, cardiovascular effects, fatal, immediate hypersensitivity reactions, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, paradoxical bronchospasm, life-threatening, increased pulse rate, systolic blood pressure, diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, pre-existing diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, asthma-related death, death"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG changes, potential for cardiac arrhythmias, cardiac arrhythmias, PR interval prolongation, QTc interval prolongation, QRS interval prolongation, pre-existing cardiac disease, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis, Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"nephrogenic systemic fibrosis, NSF, fatal fibrosis, debilitating fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function, death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Dialysis, Extravasation, Injection Site Reactions, Overestimation of Extent of Malignant Disease."
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, death, increased ALT, increased AST, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, elevated transaminases, jaundice, Interstitial Lung Disease (ILD), pneumonitis, fatal ILD/pneumonitis, QT Interval Prolongation, ventricular tachyarrhythmias, Torsade de pointes, sudden death, hyperglycemia, bradycardia, sinus bradycardia, pancreatitis, skeletal anomalies in rats and rabbits, death"
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, neutropenia, lymphopenia, hypophosphatemia, pain in extremity, muscle spasm, dizziness, headache, pyrexia, weight increased, abdominal pain, dyspepsia, dysphagia, rash, renal cyst, syncope, neuropathy, gait disturbance, hypoesthesia, muscular weakness, neuralgia, peripheral neuropathy, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, hypokalemia, hepatic failure, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, dysesthesia, acute respiratory distress syndrome, arrhythmia, sepsis, grade 3/4 visual impairment"
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, bradycardia, Severe Visual Loss, Embryofetal Toxicity, elevations in ALT, elevations in AST, transaminase elevations, fatal ILD, drug-related ILD/pneumonitis, QTc prolongation, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, symptomatic bradycardia, syncope, Grade 4 visual field defect, vision loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity."
89,BEPREVE,adverse reactions,"mild taste, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal morbidity, neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes, damage to the photoreceptors"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, death (in context of suicide), retinal abnormalities, potential vision loss, hydronephrosis, renal function impairment, skin discoloration (blue, grey-blue or brown), perivascular pigmentation (bone spicule pattern), retinal pigment epithelium clumping, abnormal visual acuity, retina dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, urinary hesitation, dysuria, confusional state, psychotic symptoms, hallucinations, withdrawal seizures"
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, anaphylaxis, urticaria, rash, bronchospasm, itching, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination."
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, pain in extremity, thrombotic microangiopathy with acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, Thrombotic Complications, Thromboembolic Complications, Portal vein thrombosis, Hepatic decompensation, Ascites, Encephalopathy, Liver enzyme elevations, ALT increase, AST increase, Bilirubin increase, Indirect hyperbilirubinemia, Liver injury, Hepatic decompensation (repeated), Thrombotic event, Venous events, Arterial events, Factor V Leiden, ATIII deficiency, Antiphospholipid syndrome, Chronic liver disease, thromboembolism, Portal vein thrombosis (PVT), Abdominal pain, Nausea, Vomiting, Diarrhea, Cataracts"
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (reversible posterior leukoencephalopathy syndrome), proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, increased lipase, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, decreased hemoglobin, decreased lymphocytes, decreased platelets, decreased white blood cells, increased creatinine, decreased bicarbonate, hypocalcemia, increased ALP (alkaline phosphatase), hyperglycemia, increased amylase, increased ALT (alanine aminotransferase), increased AST (aspartate aminotransferase), hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, increased hemoglobin, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, death"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbate symptoms, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma, aspirin hypersensitivity, death"
107,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst (including polydipsia), volume depletion, increased urination, polyuria, pollakiuria, nocturia, serum creatinine increase, eGFR decrease, hypoglycemia, overall hypoglycemic events, severe hypoglycemic events, phimosis, asymptomatic bacteriuria, cystitis, hematocrit increase"
108,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, macrovascular outcomes"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, abdominal discomfort, nausea, diarrhea, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, congestive, acute, vertigo, tinnitus, hypothyroidism, conjunctivitis, allergic, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, conjunctival, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, general, pitting, due to cardiac disease, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, anemia, iron deficiency anemia, leukopenia."
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), Tardive dyskinesia, Hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular risk, cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, cardiac arrhythmias, hyperpyrexia, muscle rigidity, altered mental status, catatonic signs, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, creatine phosphokinase elevation, myoglobinuria (rhabdomyolysis), acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system (CNS) pathology, somnolence, sedation, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, bone density decreased, mammary gland proliferative changes, disruption of body temperature regulation, Dysphagia, esophageal dysmotility, aspiration pneumonia."
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, Immunogenicity, Liver Enzyme Abnormalities, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness, death"
114,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, serious hypersensitivity reaction, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration."
115,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death."
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, Gastritis, intestinal obstruction, death."
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, death, hypersensitivity, generalized rash, erythema, hypotension, bronchospasm"
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, abdominal pain, fever, persistent constipation, renal failure, death, fetal harm, embryotoxic, fetotoxic, abortifacient, death."
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, severe immune-mediated adverse reactions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), hypersensitivity, anaphylaxis, death"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, severe immune-mediated reactions, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe immune-mediated enterocolitis, life-threatening enterocolitis, fatal enterocolitis, moderate enterocolitis, intestinal perforation, complications (death), severe enterocolitis, Grade 3-5 enterocolitis, Grade 2 enterocolitis, severe hepatotoxicity, life-threatening hepatotoxicity, fatal hepatotoxicity, hospitalization (for hepatotoxicity), moderate hepatotoxicity, Grade 3-5 hepatotoxicity, Grade 2 hepatotoxicity, immune-mediated hepatitis, grades of hepatotoxicity, severe immune-mediated dermatitis, life-threatening dermatitis, fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, full thickness dermal ulceration, necrotic dermatitis, bullous dermatitis, hemorrhagic dermatitis, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, immune-mediated neuropathies, myasthenia gravis, Guillain-Barre syndrome, severe immune-mediated endocrinopathies, hospitalization (for endocrinopathies), adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hypopituitarism, other immune-mediated adverse reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, severe immune-mediated adverse reactions, immune-mediated ocular disease, death."
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased urination, Male Genital Mycotic Infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic Hypotension, Renal Failure, Blood Creatinine Increase, Bone Fractures, Hypersensitivity Reactions, Angioedema, Urticaria, Anaphylactic Reactions, Severe Cutaneous Adverse Reactions, Hematocrit Increase, Increase in Serum Inorganic Phosphorus, Hyperphosphatemia, Increase in Serum Low-Density Lipoprotein Cholesterol"
124,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation, pustulation, erosion, ulceration, erythema, crusting, swelling, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, metabolism and nutrition disorders, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, blurred vision, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, lipid abnormalities, proteinuria, supine systolic blood pressure increase, supine diastolic blood pressure increase, pulse rate increase, weight loss, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome."
128,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors, worsening, emergence of suicidal thoughts and behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, suicidality, suicidal thoughts, suicidal behavior, unusual changes in behavior, serotonin syndrome, elevated blood pressure, hypertension, abnormal bleeding, bleeding events, angle closure glaucoma, mania, hypomania, manic episodes, discontinuation syndrome, discontinuation symptoms, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms (nausea, vomiting, diarrhea), tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, activation of mania/hypomania, dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances (paresthesia, electric shock sensations), confusion, lethargy, emotional lability, hypomania, tinnitus, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, coma, respiratory arrest, death, dyspnea, cough, chest discomfort"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, peripheral neuritis, neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, laboratory abnormalities, AST elevation, ALT elevation, amylase elevation, creatine kinase increase, urine RBC increase, hematuria, bone density decrease, fractures, proteinuria, serum creatinine increase, creatinine clearance decrease, cholesterol level changes, lipid alterations, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, hepatitis, liver enzymes increase, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, death"
132,STRIBILD,warnings and precautions,"new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, loss of therapeutic effect of STRIBILD, development of resistance, clinically significant adverse reactions, decreases in bone mineral density (BMD), redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, liver decompensation, liver failure, exacerbations of hepatitis B, renal impairment, proximal renal tubulopathy, severe hypophosphatemia, bone pain, pain in extremities, fractures, muscular pain, weakness, persistent bone pain, increased bone turnover, osteomalacia, arthralgias, hypophosphatemia, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, progressive multifocal leukoencephalopathy, death, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, proteinuria, immunogenicity, anti-belatacept antibodies, new-onset diabetes after transplantation, NODAT, dyslipidemia, urinary tract infection, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation."
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), malignancies, serious infections, increased risk of infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder, PTLD, Other malignancies, Progressive Multifocal Leukoencephalopathy, PML, Other serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy, PVAN, kidney graft loss, deterioration of renal function, Liver transplant related graft loss, death, Acute rejection, Graft loss, Corticosteroid minimization related increased rate and grade of acute rejection, particularly Grade III rejection, Immunizations related complications from live vaccines."
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, rash erythematous, rash macular, maculo-papular, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, serious adverse reactions, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, delayed-onset reactions, recurrent reactions, flu-like illness, arthralgia, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome secondary to membranous glomerulonephritis, necrotizing skin lesions, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated reactions, systemic immune-mediated reactions, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, sudden cardiac death, cardiac resuscitation, defibrillation, immunogenicity, loss of motor function, ventilator dependence, death"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function, death"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, death, debilitating fibrosis, fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, rapid decrease in kidney function, Anaphylactic reactions, allergies, bronchial asthma, allergic disorders, hypersensitivity reactions, acute kidney injury requiring dialysis, local tissue reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, reduced hepatic contrast, severe renal failure, severe hepatic failure, elevated serum ferritin levels, reduced hepatic contrast with high serum bilirubin."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia."
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality, genotoxicity, nausea, vomiting, diarrhea, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, agranulocytosis, thrombocytopenia, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, death"
145,VICTRELIS,warnings and precautions,"embryofetal toxicity, birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity, serious acute hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, dose modifications, treatment discontinuation, erythropoiesis stimulating agents use, transfusion, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, pancytopenia, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies."
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, nausea, abdominal pain, retching, vomiting, acute respiratory illness, hypersensitivity reactions, acute exacerbation of respiratory compromise, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, death, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, death"
150,SIRTURO,boxed warnings,"Increased Mortality, death, QT Prolongation, significant ventricular arrhythmia, QTcF interval >500 ms."
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, increased mortality, death, Clinically significant ventricular arrhythmia, syncope, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium deficiency, serum magnesium deficiency, serum potassium deficiency."
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"image interpretation errors, false positives, unintentional radiation exposure, risk for image misinterpretation, errors, severe brain atrophy, motion artifacts, increased risk of cancer, death"
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, Diarrhea, Stomatitis, Decreased weight, Decreased appetite, Nausea, Fatigue, Oral pain, Hair color changes, Dysgeusia, Abdominal pain, Constipation, Increased AST, Increased ALT, Lymphopenia, Increased alkaline phosphatase, Hypocalcemia, Neutropenia, Thrombocytopenia, Hypophosphatemia, Hyperbilirubinemia, Asthenia, Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Dysphagia, Dyspepsia, Hemorrhoids, Vomiting, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Hyponatremia, Hypomagnesemia, Hypokalemia, Pneumonia, Septicemia, Cardiac arrest, Respiratory failure, Death, Increased lipase, Pancreatitis, Tracheal fistula formation, Increased levels of thyroid stimulating hormone (TSH), Erythema, Hyperkeratosis, Malignant hypertension."
155,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, severe hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal (GI) perforations, fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, acute myocardial infarction, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, erosion, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations, death"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Infections, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Death, Hypercholesterolemia, Hyperglycemia, Increased aspartate transaminase (AST), Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Hemoglobin decreased, White blood cell (WBC) decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Bicarbonate decreased, Aspartate transaminase (AST) increased, Alanine transaminase (ALT) increased, Hypophosphatemia, Calcemia, Potassium decreased, Menorrhagia, Haemorrhage, Erythema, Paresthesia, Dizziness, Vomiting, Constipation, Dysgeusia, Insomnia, Hypertension, Dry mouth, Arthralgia, Back pain, Pain in extremity, Dyspnea, Epistaxis, Oropharyngeal pain, Pyrexia, Diarrhea, Enteritis, Enterocolitis, Colitis, Defecation urgency, Steatorrhea, Urinary tract infection, Nail disorders, Pruritus, Dry skin, Xeroderma, Gastroenteritis, Diabetes mellitus, Muscle spasms, Weight decreased, Hyperglycemia, Lymphopenia, Decreased hemoglobin, Hypophosphatemia, Increased alkaline phosphatase, Neutropenia, Weight decreased, Chest pain, Chills, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hot flush, Edema peripheral, Depression, Otitis media, Decreased appetite, Anxiety, Aggression, Obsessive-compulsive disorder, Amenorrhea, Menstrual irregularities, Vaginal hemorrhage, Cellulitis, Hyperglycemia, Creatinine increased, Hand-foot syndrome, Palmar-plantar erythrodysesthesia syndrome, Acneiform dermatitis, Angioedema, Asthenia, Glossodynia, Gingival pain, Glossitis, Lip ulceration, Nasopharyngitis, Pneumonia, Bronchitis, Cystitis, Sinusitis, Candidiasis, Sepsis, Hepatitis C, Pneumonitis, Interstitial lung disease, Lung infiltration, Pulmonary fibrosis, Abdominal pain, Diarrhea, Nausea, Fever, Vomiting, Constipation, Fatigue, Malaise, Fever, Musculoskeletal pain, Pain in extremity, Headache, Allergic reactions, Stomatitis, Mouth ulceration, Aphthous stomatitis, Dysgeusia, Hypersensitivity, Bronchospasm, Convulsion, Hypercholesterolemia, Menorrhagia, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, vaccinations, embryo-fetal toxicity, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, pneumocystis jiroveci pneumonia (PJP), pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, viral infections, hepatitis B virus, sepsis, respiratory failure, hepatic failure, angioedema with concomitant ACE inhibitors, hyperglycemia, hyperlipidemia, hypertriglyceridemia, drug-drug interactions, hepatic impairment"
159,BREO,adverse reactions,"asthma-related death, hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, Immunosuppression, Hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, mouth and pharynx infections, increased risk of pneumonia, worsening of infections, serious course of chickenpox, fatal course of measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Loss of strength or energy (asthenia), Pancreatitis (acute or chronic), Photosensitivity-related adverse reactions (including photosensitivity reaction, polymorphic light eruption, and sunburn), Volume Depletion-Related Adverse Reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration), Falls, Significant renal function decline, Increased blood creatinine, Decreased glomerular filtration rate, Renal impairment, Acute renal failure, Vulvovaginal mycotic infection, Vulvovaginal candidiasis, Vulvovaginitis, Candidal balanitis, Balanoposthitis, Recurrent genital mycotic infections, Phimosis, Increases in Serum Potassium, Severe elevations in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, death"
169,NESINA,warnings and precautions,"Acute pancreatitis, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, arthralgia, severe joint pain, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, serum alanine aminotransferase elevations, liver test abnormalities."
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Dizziness, Pneumonia, Eczema, Pruritus, Ischemic strokes, Hemorrhagic strokes, Peripheral arterial occlusive disease, Lymphoma."
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure (BP), Reduction in Heart Rate, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, Atrioventricular Blocks, first-degree AV block, second-degree AV block, Mobitz Types I [Wenckebach], 2:1 AV blocks, third-degree AV block, junctional escape, asystole, unexplained death, syncope, herpes zoster, influenza, sinusitis, pneumonia, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus, antibody-negative, vaccination, forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, elevation of liver transaminases, hepatitis, jaundice, dark urine, fetal harm, immune system effects, lymphocyte counts, death."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 cytopenias, Grade 4 cytopenias, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, motor neuropathy, sensory neuropathy, fetal harm, teratogenicity, hypokalemia, hypomagnesemia, congestive heart failure, bradyarrhythmias"
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, death"
175,INTELENCE,warnings and precautions,"severe skin reactions, life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rash, Grade 4 rash, facial edema, hepatitis, eosinophilia, angioedema, death, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
176,AMYVID,adverse reactions,"Headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, radiation risk, unintentional radiation exposure, Risk for Image Misinterpretation, other Errors, extensive brain atrophy, motion artifacts, increased risk of cancer."
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"neonatal toxicity, gasping syndrome, eye irritation, contact dermatitis, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, allergic dermatitis, irritant dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, clinically significant weight loss, drug interactions, loss of efficacy, increased adverse reactions, worsening of depression, suicidal behavior, discontinued treatment due to depression, serious depression, suicidal ideation, attempted suicide, death"
182,ILARIS,adverse reactions,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), mild injection site reaction, moderate injection site reaction, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, vertigo, hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild transient decreases in platelet counts, elevations of transaminases, high ALT, AST, mild elevations of serum bilirubin"
183,ILARIS,warnings and precautions,"serious infections, infections, recurring infections, upper respiratory tract infections, unusual infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, serious infections with TNF inhibitors, new tuberculosis, reactivation of latent tuberculosis, immunosuppression, malignancies, hypersensitivity reactions, anaphylactic reactions, impaired immune response, immune response to infections, ineffective vaccinations, worsening of rheumatic conditions, macrophage activation syndrome (MAS), death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, breast tenderness, pain, menstrual disorders, vomiting, acne, mood changes, increased weight, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, altered mood, depressed mood, dysthymic disorder, crying, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, VTE, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, jaundice, hepatic adenomas, intra-abdominal hemorrhage, death, hepatocellular carcinoma, cholestasis, hypertension, gallbladder disease, decreased glucose tolerance, dyslipidemia, adverse lipid changes, hypertriglyceridemia, pancreatitis, headache, recurrent headaches, persistent headaches, severe headaches, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, chloasma, hereditary angioedema"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria"
189,ONFI,adverse reactions,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, drooling, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema"
190,ONFI,warnings and precautions,"somnolence, sedation, CNS depression, central nervous system depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, habituation, dependence, suicidal behavior, suicidal ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, mood changes, thoughts about self-harm"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, elevated hepatic transaminases, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, Progressive multifocal leukoencephalopathy (PML), death, prolonged lymphopenia, decrease in lymphocyte counts, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory and orientation, confusion, personality changes, infections, serious infections, flushing, warmth, redness, itching, burning sensation, serious flushing symptoms."
193,DYSPORT,adverse reactions,"fatal event, distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, cervical dystonia, feeling abnormal, disturbance in attention, eyelid disorder, muscle atrophy, laboratory findings, blood glucose, electrocardiographic findings, reduced heart rate, injection site reaction, injection site bruising, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, eyelid ptosis, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, blood present in urine, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, photophobia, influenza-like illness, amyotrophy, burning sensation, hypoesthesia, excessive granulation tissue, immunogenicity, antibody formation, binding antibodies, neutralizing antibodies, sensation of heaviness, gait disturbance, hypertonia."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbation of clinical effects of treatment, transmission of Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, weakening of muscles, spread of toxin effects, feeding tube requirement, aspiration, weakening of neck muscles, respiratory failure, surgical alterations to facial anatomy, excessive weakness, atrophy, facial asymmetry, inflammation at the injection site, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, inability to lessen glabellar lines, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia, respiratory compromise, transmission of viral diseases, immune reaction, death."
196,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, death"
197,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III heart failure, NYHA Class IV heart failure, control hypertension, hypokalemia, monitor blood pressure, serum potassium, symptoms of fluid retention, adrenocortical insufficiency, hepatotoxicity, drug interruption, dose modification, discontinuation, hypertension, grade 3 hypertension, grade 4 hypertension, grade 3 hypokalemia, grade 4 hypokalemia, grade 3 edema, grade 4 edema, CYP17 inhibition, blood pressure increases, heart failure, recent myocardial infarction, ventricular arrhythmia, NYHA Class II heart failure, increase in liver enzymes, ALT increase, AST increase, ALT > 5* ULN, AST > 5* ULN, elevated baseline ALT, elevated baseline AST, liver function test elevation, serum transaminases increase, bilirubin levels increase, moderate hepatic impairment, serum total bilirubin increase, hepatotoxicity symptoms, AST or ALT > five times the ULN, bilirubin > three times the ULN, AST or ALT > 20* ULN, bilirubin > 10* ULN"
198,DUAVEE,adverse reactions,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, unusual vaginal bleeding, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of the mouth or tongue, worsening of medical problems, asthma, diabetes, epilepsy, migraines, lupus, liver problems, porphyria, breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in chest or legs with or without shortness of breath weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, monitor thyroid function, coronary heart disease, nonfatal myocardial infarction, silent myocardial infarction, CHD death, deep vein thrombosis (DVT), probable dementia, elevated blood pressure, pancreatitis, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, exacerbation of hepatic hemangiomas, no indication for premenopausal use, laboratory tests alterations, drug-laboratory test interactions, accelerated prothrombin time, partial thromboplastin time, platelet aggregation time, increased platelet count, increased coagulation factors and activity, decreased anticoagulant factors levels and activity, increased fibrinogen levels and activity, increased plasminogen levels and activity, increased binding proteins, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Concomitant Illness, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, oral paresthesia, dysgeusia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, anxiety, depression, dysmenorrhea, headache, dyspnea, rash, muscle strain, abdominal pain, glossodynia, irritability, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, oropharyngeal pain, nasal congestion, edema peripheral, hypertension, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling, inflammation, choking, oropharyngeal muscular dysfunction, hypoesthesia"
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, hyperglycemia, dyslipidemia, weight gain, Hypersensitivity Reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, Hemodynamic Effects, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, Suicide, death, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, somnolence, sedation, hypersomnia, Body Temperature Regulation, pyrexia, feeling hot, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis."
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, increase incidence of bleb formation, corneal or scleral thinning, perforations, bacterial infections, suppressed host response, secondary ocular infections, mask infection, enhance existing infection, viral infections, prolong the course of viral infections, exacerbate the severity of viral infections, herpes simplex, fungal infections, corneal ulceration, fungus invasion."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, hepatotoxicity, diarrhea/colitis, elevated transaminases, gastroesophageal reflux disease, stomatitis, vomiting, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, hepatotoxicity, severe diarrhea, diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, death, elevations in ALT or AST, diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, seroconversion to anti-ecallantide antibodies, neutralizing antibodies, loss of efficacy, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, hereditary angioedema, clinical hypersensitivity"
211,KALBITOR,warnings and precautions,"hypersensitivity reactions, anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate Hepatic Impairment, Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Neutropenia, Peripheral Sensory Neuropathy, Fatigue, Nausea, Anemia, Upper Respiratory Tract Infection, Diarrhea, Pyrexia, Rash, Thrombocytopenia, Cough, Vomiting, Peripheral Motor Neuropathy, Lymphadenopathy, Headache, Dizziness, Chills, Pain, Edema Peripheral, Constipation, Pruritus, Alopecia, Night Sweats, Dry Skin, Dyspnea, Oropharyngeal Pain, Arthralgia, Myalgia, Back Pain, Pain in Extremity, Muscle Spasms, Insomnia, Anxiety, Decreased Appetite, Weight Decreased, Infusion Reactions, Non-infectious Pulmonary Toxicity, Pulmonary Embolism, Pneumonitis, Pneumothorax, Pyelonephritis, Septic Shock, Supraventricular Arrhythmia, Urinary Tract Infection, PML, Stevens-Johnson Syndrome, Acute Respiratory Distress Syndrome, Paraesthesia, Febrile Neutropenia, Hyperglycemia, Pancreatitis, Interstitial Lung Disease, ARDS, Toxic Epidermal Necrolysis, Death"
213,ADCETRIS,boxed warnings,"Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatocellular injury, transaminases elevation, bilirubin elevation, progressive multifocal leukoencephalopathy (PML), noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, embryo viability decrease, fetal malformations, death"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"growth of resistant organisms, overgrowth of non-susceptible organisms, fungi, super-infection"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbation of heart failure, rebound hypertension"
219,XTANDI,adverse reactions,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infection resulting in death, falls, fall-related injuries, hypertensive crisis, joint injuries, hematomas, death"
220,XTANDI,warnings and precautions,"seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Serious adverse reactions, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Hematology Parameters, Platelet Count Low, Absolute Neutrophil Count Low, Hemoglobin Low, Biochemistry Parameters, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus Low, Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Toxic hepatitis, Cytolytic hepatitis, Liver disorder, Liver injury, Drug hypersensitivity, Pneumonia, Bronchopneumonia, Lobar pneumonia, Primary atypical pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption, Death"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug-Induced Liver Injury, ALT Elevation, AST Elevation, Transaminase Elevations, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Severe Fluid Retention, Renal Toxicity, Decline in eGFR, Kidney Failure, Embryofetal Toxicity, Fetal harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage, acute symptomatic hyperammonemia, uncontrolled hyperammonemia."
225,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, administration reactions, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, infections and infestations, viral infections, bacterial infections, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, pyrexia, blood and lymphatic disorders, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions (including anaphylactic reaction), sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin exfoliation, bullous skin reactions."
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, serious infection, sepsis, latent TB, active TB, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated fungal infection, systemic illness, bacterial infections, viral infections, opportunistic pathogens, Legionella, Listeria, chronic infection, recurrent infection, lymphoma, malignancies, cancer"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, death, tuberculosis reactivation, hepatosplenic T-cell lymphoma, melanoma, Merkel cell carcinoma, congestive heart failure, new onset congestive heart failure, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, serious infections due to abatacept, serious infections due to anakinra, neutropenia, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, infections from live vaccines, disseminated infections, infections from therapeutic infectious agents, systemic hypersensitivity reactions."
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in Extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis Viral, Fatal Anaphylaxis, Erythematous Rash, Pruritus, Eyelid Edema, Headache, Dyspnea, death"
229,BENLYSTA,warnings and precautions,"mortality, deaths, serious infections, fatal infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, depression, suicidality, malignancies, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, infusion reactions, bradycardia, urticaria, hypotension, psychiatric events, insomnia, anxiety, death"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, anticholinergic CNS effects, severe hepatic impairment, severe renal impairment, death."
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction, death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, dose-related serious adverse reactions, higher plasma levels of drug, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, false positives, radiation risk, image interpretation errors, image misinterpretation, errors, extensive brain atrophy, motion artifacts, increased risk of cancer"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events, discontinuation, confusional state, death"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, renal impairment, allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
239,ADCETRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Embryo-fetal toxicity, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, serious infections, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis, hyperglycemia, Stevens-Johnson syndrome, tumor lysis syndrome, death"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritus, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, ""Gasping Syndrome"", hypotension, metabolic acidosis, kernicterus, death, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, Laboratory test alterations, decreased hemoglobin, neutropenia, platelets decreased, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), hypertriglyceridemia, lymphopenia, increased alanine transaminase (ALT), thrombocytopenia, anemia, leukopenia, stomatitis, rash, fatigue, diarrhea, decreased appetite, abdominal pain, nausea, fever, cough, headache, asthenia, upper respiratory tract infection, pneumonia, bronchitis, cystitis, sinusitis, candidiasis, sepsis, hepatitis C, hypercholesterolemia, increased alanine transaminase (ALT), hypertriglyceridemia, dysgeusia, pruritus, alopecia, hypertension, musculoskeletal pain, gastrointestinal pain, vomiting, weight decreased, musculoskeletal and connective tissue disorders, exanthema, diabetes mellitus, arthralgia, back pain, pain in extremity, dyspnea, epistaxis, edema peripheral, pyrexia, insomnia, urinary tract infection, abdominal pain, investigation related abnormalities, metabolic disorders, alopecia, dry skin, erythema, mucositis, oral pain, acneiform dermatitis, chest pain, hyperglycemia, death, acute renal failure, acute respiratory distress, cardiac arrest, hepatic failure, pulmonary embolism, myocardial infarction with congestive heart failure, sudden death, thrombotic events, pneumocystis jiroveci pneumonia (PJP), pleural effusion, pharyngolaryngeal pain, rhinorrhea, impairment of wound healing, hematologic disorders, hemorrhage, hand-foot syndrome, palmar-plantar erythrodysesthesia syndrome, nail disorder, erythema, onychoclasis, altered mood, anxiety, insomnia, dizziness, paresthesia, tachycardia, congestive cardiac failure, amenorrhea, irregular menstruation, dysmenorrhea, menorrhagia, metrorrhagia, unspecified menstrual irregularity, dry mouth, hemorrhoids, dysphagia, creatinine increased, decreased appetite, otitis media, depression, hypersensitivity, ovarian cyst, dysmenorrhea, amenorrhea, elevated partial thromboplastin time, cellulitis, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, respiratory failure, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, aggression, agitation, pneumonia, gastroenteritis, pyrexia, dermatitis allergic, urticaria, lymphocytopenia, hypertriglyceridemia, respiratory failure, hepatic failure, pneumocystis jiroveci pneumonia (PJP), pleural effusion, pharyngolaryngeal pain, rhinorrhea, hyperglycemia, amenorrhea, irregular menstruation, dysmenorrhea, menorrhagia, metrorrhagia, unspecified menstrual irregularity, anxiety, aggression or other behavioral disturbance, hypophosphatemia, weight decreased, chest pain, hypertension, jaw pain, sleep disorders, ocular disorders, hot flush, deep vein thrombosis, epistaxis, dyspnea/dyspnea exertional, oropharyngeal pain, acne, muscle spasms, dizziness, otalgia, depression, taste loss, endocrine disorders, gingival pain/swelling/ulceration, menorrhagia, otitis media, muscular weakness, exanthema, hypersensitivity, ovarian cyst, pneumonitis, hypertension, chills, impaired wound healing, angioedema, eyelid edema, conjunctivitis, deep vein thrombosis, renal failure, hot flush, tachycardia, jaw pain, musculoskeletal pain, gingival bleeding, nausea, pain in extremity, insomnia, pneumonia, epistaxis, hypersensitivity, increased blood luteinizing hormone (LH) levels, pneumonitis, angioedema."
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, seizures, renal impairment, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, hypertension, fatigue, nausea, injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, anxiety, back pain, claustrophobia, dizziness, feeling cold, chills, insomnia, neck pain, infusion site rash, dysgeusia, pruritus, urticaria, flushing"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, visual impairment, gastrointestinal disorders, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, asthenia, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, nervous system disorders, balance disorder, seizure, dysarthria, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, rash, vascular disorders, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, dizziness and disturbance in gait and coordination, cognitive dysfunction, visual changes, impaired vision, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), fever, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, hypochloremia, lethargy, malaise, hypersomnia, sedation, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, suicidal thoughts or behavior, depression, unusual changes in mood or behavior, elevation in transaminases, jaundice, decreases in serum T3 and T4."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, COPD, dyspnea, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia, leukopenia (neutropenia and lymphopenia), serious infections, sepsis, fatal hepatotoxicity, serious adverse reactions, Tumor lysis syndrome, teratogenicity, embryo-fetal lethality, genotoxicity, Embryo-fetal Toxicity"
247,BENLYSTA,all-concat,"mortality, death, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, viral gastroenteritis, immunogenicity, fatal anaphylaxis, progressive multifocal leukoencephalopathy (PML), suicidal behavior, anxiety, upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, JC virus-associated PML, neurological deficits, non-melanoma skin cancers, rash, fatigue, myalgia, headache, facial edema, bradycardia, urticaria, hypotension, psychiatric events, suicidal thoughts, live vaccines interaction, erythematous rash, pruritus, eyelid edema, dyspnea, infections leading to discontinuation, infections resulting in death, secondary transmission of infection"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
251,BOSULIF,all-concat,"diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, fluid retention, hepatotoxicity, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT elevation, SGOT/AST elevation, lipase elevation, phosphorus low, total bilirubin high, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity (additional context), abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, gastrointestinal toxicity, myelosuppression, hepatic toxicity, renal toxicity, embryofetal toxicity"
252,BREO,all-concat,"asthma-related death, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias, PR interval prolongation, QTc interval prolongation, QRS interval prolongation"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, allergic reactions, anaphylaxis, Radiation risk, tissue inflammation, false positive results, false negative results, death"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, reactivation of latent tuberculosis, invasive fungal infections (histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis), bacterial, viral and other infections due to opportunistic pathogens (Legionella, Listeria), heart failure, new onset CHF, worsening congestive heart failure, increased mortality due to CHF, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, pancytopenia, aplastic anemia, neutropenia, thrombocytopenia, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, hepatosplenic T-cell lymphoma, acute leukemia, chronic leukemia, lupus-like syndrome, angioedema, hypotension, serum sickness, syncope (vasovagal)."
257,CLEVIPREX,all-concat,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia, negative inotropic effects, rebound hypertension, death"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, bullous eruption, QT prolongation, sudden death"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, vomiting, dysphagia, dyspepsia, hemorrhoids, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, death"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, hypersensitivity, anaphylactic reactions, skin reactions, ""Red-Man Syndrome"", alanine aminotransferase (ALT) elevations, liver test abnormalities (ALT, AST, bilirubin), Clostridium difficile-associated diarrhea (CDAD), death"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain, anaphylactic reactions, thyroid neoplasia"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF (Nephrogenic Systemic Fibrosis), nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions (site inflammation, extravasation, pruritus, and warmth), bradycardia, tachycardia, arrhythmia, hypersensitivity, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, acute kidney injury, anaphylactic reactions, death."
264,DUAVEE,all-concat,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, deep vein thrombosis (DVT), probable dementia, breast cancer, ovarian cancer, gallbladder problems, loss of vision, high blood pressure, increased fats in blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of mouth or tongue, worsening of medical problems, asthma, diabetes, epilepsy, migraine, porphyria, lupus, liver problems, abdominal pain, throat pain, neck pain, blood clots, stroke, heart attack, cancer of lining of uterus, dementia, gallbladder disease, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, pancreatitis, cholestatic jaundice, hypothyroidism, hypocalcemia, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance, death"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal thinning, sclera thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, bleb formation, bacterial infections, viral infections, fungal infections, death"
266,DYSPORT,all-concat,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, nasal congestion, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, breathing difficulty, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, photophobia, influenza-like illness, amyotrophy, burning sensation, erythema, excessive granulation tissue, immunogenicity, gait disturbance, hypertonia, sensation of heaviness, blood present in urine, bronchitis, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site bleeding, erythema, hematoma, pain in extremity, back pain, constipation, diarrhea, blood triglycerides increased, cough, hypertension, convulsion, syncope, hypoaesthesia, partial seizures, fatigue, asthenia, injury, bruising, haemorrhage, injection site erythema, swelling, hematoma, dysphagia, facial paresis, hypoesthesia, influenza, facial paresis, excessive granulation tissue, death"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low red blood cell (RBC) counts, abnormal platelet counts, abnormal white blood cell (WBC) counts, rash, pruritus, angioedema, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, renal failure, death"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, Spinal/epidural anesthesia or puncture, death, Intracranial bleed, hemorrhagic stroke, Gastrointestinal (GI) bleed, fatal bleeding, Hypersensitivity reactions, drug hypersensitivity, skin rash, anaphylactic reactions, allergic edema, syncope, hematomas, gingival bleeding, ocular hemorrhage (including conjunctival hemorrhage), hemoptysis, hypersensitivity, muscle hemorrhage, rectal hemorrhage, epistaxis, contusion, hematuria, hematoma, menorrhagia, wound secretion, incision-site hemorrhage, operative hemorrhage, hemorrhagic anemia, hematochezia, hemorrhoidal hemorrhage, gastrointestinal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, injection-site hematoma, vessel puncture-site hematoma, thrombotic events, pathological bleeding, pathological hemorrhage, Spinal/Epidural Anesthesia or Puncture, long-term paralysis, permanent paralysis, prosthetic heart valves, Acute PE, hemodynamically unstable patients, thrombolysis or pulmonary embolectomy"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
270,EOVIST,all-concat,"nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, fatal or debilitating fibrosis, acute kidney injury, anaphylactoid reactions, shock, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, acute kidney injury requiring dialysis, extravasation, local tissue reactions, myocyte necrosis and inflammation, falsely high or low serum iron values, impaired EOVIST imaging performance, elevated serum ferritin levels, reduced hepatic contrast, death."
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hepatic disorders, pancreatic disorders, immunogenicity, anaphylaxis, Grade 3 hypersensitivity reactions, Grade 4 hypersensitivity reactions, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal detachment, retinal tear, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, death, cerebrovascular accidents, transient ischemic attacks, QT prolongation, arrhythmia, sudden death, torsade de pointes, Neuroleptic Malignant Syndrome, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, hyperlipidemia, low-density lipoprotein increase, high-density lipoprotein decrease, triglyceride increase, cholesterol increase, weight gain, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, galactorrhea, gynecomastia, impotence, hyperthermia, aspiration pneumonia, priapism, cognitive impairment, motor impairment"
274,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased Urination, Male Genital Mycotic Infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with Urination, Pain in Extremity, Volume Depletion (including Dehydration, Hypovolemia, Orthostatic Hypotension), Renal Failure, Blood Creatinine Increase, Major Hypoglycemia, Minor Hypoglycemia, Hypersensitivity Reactions (Angioedema, Urticaria, Hypersensitivity), Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Bone Fractures."
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritus, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death."
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increased, dizziness, rash, nausea, headache, death"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, Headache, Nausea, Dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Dyspnea, Paresthesia, Loss of consciousness, Convulsion, Parosmia, Tachycardia, Palpitation, Dry mouth, Malaise, Feeling cold, Cardiac arrest, Anaphylactic shock, Circulatory collapse, Respiratory arrest, Pulmonary edema, Bronchospasm, Cyanosis, Oropharyngeal swelling, Laryngeal edema, Blood pressure increased, Chest pain, Angioedema, Conjunctivitis, Hyperhidrosis, Cough, Sneezing, Burning sensation, Pallor, Acute kidney injury, Extravasation, Overestimation of Extent of Malignant Disease in MRI of the Breast, death"
279,GILENYA,all-concat,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, nervous system disorders, migraine, gastrointestinal disorders, nausea, general disorders, administration site conditions, asthenia, musculoskeletal, connective tissue disorders, skin, subcutaneous tissue disorders, alopecia, actinic keratosis, investigations, blood triglycerides increased, dyspnea, eye disorders, vision blurred, vascular disorders, hypertension, blood, lymphatic system disorders, lymphopenia, leukopenia, neoplasms, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, syncope, herpes viral infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, varicella zoster virus, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus antibody, posterior reversible encephalopathy syndrome, PRES, ischemic stroke, cerebral hemorrhage, forced expiratory volume, diffusion lung capacity for carbon monoxide, FEV1, DLCO, fetal harm, blood pressure effects, immune system effects, death"
280,GILOTRIF,all-concat,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, Embryofetal Toxicity, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Cheilitis, Cystitis, Epistaxis, Rhinorrhea, Weight Decreased, Pyrexia, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis, dehydration, renal failure, mucosal inflammation, mouth ulceration, oral mucosa erosion, mucosal erosion, mucosal ulceration, dermatitis acneiform, nail infection, nail bed infection, blood potassium decreased, palpitations, blurred vision, abdominal pain, dyspnea, fatigue, hypokalemia, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, eye pain, red eye, abortion, death"
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, acute febrile neutrophilic dermatosis, cutaneous vasculitis, thrombocytopenia, anaphylaxis, hypotension, hypoalbuminemia, edema, hemoconcentration, death"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, death"
283,HORIZANT,all-concat,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, insomnia, asthenia, confusional state, drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma and carcinoma, tumor growth or worsening"
284,ILARIS,all-concat,"upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, decreased white blood cells, neutrophils and platelets, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, elevations of ALT and/or AST, asymptomatic and mild elevations of serum bilirubin, tuberculosis, malignancies, hypersensitivity reactions, anaphylactic reactions, macrophage activation syndrome (MAS), death"
285,IMBRUVICA,all-concat,"hemorrhage, bleeding, bruising, petechiae, infections, fever, cytopenias, neutropenia, thrombocytopenia, anemia, fatigue, musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea, rash, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, sinusitis, urinary tract infection, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, renal failure, creatinine increased, subdural hematoma, stomatitis, dyspepsia, muscle spasms, arthralgia, decreased appetite, dehydration, nervous system disorders, second primary malignancies, skin cancer, tumor lysis syndrome, miscarriage, embryo-fetal toxicity, anaphylactic shock, urticaria, angioedema, hemorrhage, gastrointestinal bleeding, hematuria, post procedural hemorrhage, subdural hematoma, progressive multifocal leukoencephalopathy (PML), atrial fibrillation, atrial flutter, non-melanoma skin cancer, non-skin carcinomas, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, oropharyngeal pain, peripheral neuropathy, chills, pruritus, gastroesophageal reflux disease, arthropathy, death"
286,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation and fistula formation, thyroid dysfunction, wound healing complications, RPLS, elevation of liver enzymes, hepatic impairment, fetal harm, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, cardiac failure, hypothyroidism, hyperthyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), moderate to severe proteinuria, alanine aminotransferase (ALT) elevations, death."
287,INTELENCE,all-concat,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, DRESS, rhabdomyolysis, toxic epidermal necrolysis, Stevens-Johnson syndrome, fatal cases of toxic epidermal necrolysis, death"
288,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (asthenia), pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)"
289,JARDIANCE,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Urinary tract infection, Female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst, Volume Depletion, Dehydration, Orthostatic hypotension, Syncope, Polyuria, Pollakiuria, Nocturia, Serum creatinine increases, eGFR decreases, Phimosis, Asymptomatic bacteriuria, Cystitis, Increase in Hematocrit, Vaginitis bacterial, Balanoposthitis, Balanitis, Scrotal abscess, Penile infection, Vulvovaginal candidiasis, Vulvitis, Vulvovaginal mycotic infection, Vaginal infection, Genital infection, Genital candidiasis, Genital infection fungal, Genitourinary tract infection, Cervicitis, Urogenital infection fungal"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, death, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, febrile neutropenia, infections, ventricular fibrillation, cerebral hemorrhage, Arrhythmia, Nausea, Vomiting, Constipation, Abdominal Pain, Dyspepsia, Fatigue, Asthenia, Pyrexia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Back Pain, Arthralgia, Muscle Spasms, Peripheral Neuropathy, Dysgeusia, Dizziness, Headache, Dysuria, Cough, Hypotension, Gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, hypotension, bronchospasm, Bone marrow suppression, Neutropenic infections, hypersensitivity, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, gastrointestinal toxicity, severe diarrhea, electrolyte imbalance, ileus, enterocolitis, increased AST, increased ALT, increased bilirubin, sepsis, septic shock, febrile neutropenia, infectious adverse events."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, antibodies to KALBITOR, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, Anti-ecallantide IgE, anti-P. pastoris IgE, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash, death"
293,KALYDECO,all-concat,"Transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, premature discontinuation of study drug, increased hepatic enzymes, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, death, acute renal failure, renal failure, renal impairment, renal insufficiency, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary hypertension, dyspnea, dyspnea exertional, hypertension, hypertensive crisis, hypertensive emergency, venous thrombosis, deep venous thrombosis, pulmonary embolism, embolic and thrombotic events venous, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenia purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES), embryo-fetal toxicity, multi-organ failure, dehydration, anemia, neutropenia, lymphopenia, leukopenia, diarrhea, constipation, nausea, vomiting, fatigue, pyrexia, chills, edema peripheral, asthenia, pneumonia, bronchopneumonia, nasopharyngitis, bronchitis, upper respiratory tract infection, influenza, sepsis, urinary tract infection, viral infection, hypokalemia, hypocalcemia, hypercalcaemia, hyperglycemia, hyperuricemia, hypoalbuminemia, hyponatremia, hypophosphatemia, hypomagnesemia, muscle spasms, back pain, arthralgia, pain in extremity, myalgia, muscular weakness, headache, dizziness, peripheral neuropathies NEC, hypoesthesia, paresthesia, deafness, insomnia, delirium, anxiety, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, hyperhidrosis, pruritus, rash, erythema, infusion site reaction, hypotension, toothache, abdominal pain, abdominal pain upper, dyspepsia."
295,LUMIZYME,all-concat,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, proteinuria, nephrotic syndrome, necrotizing skin lesions, flu-like illness, chills, arthralgia, pain, anaphylactic reactions, hypersensitivity reactions, immune-mediated reactions, immune-mediated cutaneous reactions, severe inflammatory arthropathy, membranous glomerulonephritis, angioedema, throat tightness, bronchospasm, hypotension, periorbital edema, face edema, chest pain, tachycardia, bradycardia, cardiac hypertrophy, pleural effusion, immune complex deposition, arrhythmias, sudden cardiac death, ventricular arrhythmias, bradycardia, general anesthesia complications, high sustained antibody titers, loss of motor function, ventilator dependence, inhibitory antibody activity, IgE antibodies, mediators of anaphylaxis, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, edema peripheral, pruritus, rash papular, local swelling, diarrhea, hyperparathyroidism, death"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, generalized rash, macular rash, maculo-papular rash, erythematous rash, pruritus, eczema, dermatitis, allergic dermatitis, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolongation, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, increased risk of death, stroke, hospitalization for heart failure, hepatocellular liver injury, acute liver failure, weight gain, dependent edema, shortness of breath, anorexia, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, itching, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, fetal harm, death."
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, breast tenderness/pain, menstrual disorders, nausea/or vomiting, acne, mood changes, increased weight, menstrual disorder, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, migraine, breast pain, discomfort, tenderness, abnormal withdrawal bleeding, uterine hemorrhage, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, retinal vein thrombosis, hepatocellular carcinoma, cholestasis, pancreatitis, amenorrhea, oligomenorrhea, breakthrough bleeding, spotting, intracyclic bleeding, hereditary angioedema, chloasma gravidarum, death"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, liver injury, jaundice, fatigue, anorexia, right upper abdominal discomfort, dark urine, severe joint pain, death"
299,NEURACEQ,all-concat,"erythema, irritation, pain, injection site reaction, image interpretation errors, false positives, radiation risk, increased risk of cancer, death"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Falls, Urinary Tract Infections, Syncope, Allergic Reactions, Bronchial Asthma"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder, other malignancies, progressive multifocal leukoencephalopathy, bacterial infections, mycobacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, polyoma virus-associated nephropathy, infusion reactions, proteinuria, immunogenicity, new-onset diabetes after transplantation, hypertension, dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, CMV, polyoma virus, herpes, cryptococcal meningitis, Chagas encephalitis with cryptococcal meningitis, cerebral aspergillosis, West Nile encephalitis, anaphylaxis, drug hypersensitivity, hypotension, immunogenicity, graft loss, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
302,ONFI,all-concat,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence or sedation, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, hallucinations, behavioral disorder, tremor, dysphoria, status epilepticus"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, suicidal ideation, back pain, insomnia, fatigue, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache, death"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, hypersensitivity reactions, allergic contact dermatitis, herpes zoster, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, vision loss, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, suicidal ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, major bleeding, decrease in hemoglobin, transfusion of packed red blood cells, bleeding at a critical site, fatal outcome, death, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleeding, anaphylactic reaction, anaphylactic shock, drug hypersensitivity, urticaria, rash, pruritus, allergic edema, symptomatic bleeding in a critical area, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, paralysis, prosthetic heart valves, neurological impairment, thromboembolic events, valve thrombosis, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, hemodynamic compromise, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal thoughts and behaviors, Suicidal ideation, Serotonin syndrome, Elevated blood pressure, Hypertension, Abnormal bleeding, Angle closure glaucoma, Activation of mania/hypomania, Mania, Hypomania, Discontinuation syndrome, Seizure, Convulsion, Hyponatremia, Interstitial lung disease, Eosinophilic pneumonia, Nausea, Dizziness, Insomnia, Hyperhidrosis, Constipation, Somnolence, Decreased appetite, Anxiety, Male sexual function disorders, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Proteinuria, Orthostatic hypotension, Tachycardia, Asthenia, Weight increased, Liver function test abnormal, Blood prolactin increased, Musculoskeletal stiffness, Syncope, Dystonia, Depersonalization, Bruxism, Urinary retention, Rash, Alopecia, Photosensitivity reaction, Angioedema, Ischemic cardiac adverse reactions, Myocardial ischemia, Myocardial infarction, Coronary occlusion requiring revascularization, Lipid abnormalities, Total cholesterol increase, LDL cholesterol increase, Triglycerides increase, Clinical worsening, Psychomotor restlessness, Agitation, Panic attacks, Hostility, Aggressiveness, Impulsivity, Akathisia, Hypomania, Irritability, Stevens-Johnson syndrome, death"
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, Back pain, Pain in extremity, Musculoskeletal pain, Hypercholesterolemia, Cystitis, Arthralgia, Nasopharyngitis, Constipation, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, Pancreatitis, Death, New Malignancies, Cataracts, Drug-related hypersensitivity reactions, Severe symptomatic hypocalcemia, Severe Bone, Joint, Muscle Pain, Marked elevation in serum PTH, Anaphylaxis, Facial swelling, Erythema, Urticaria, Cellulitis, Erysipelas, Epidermal and dermal adverse events, Dermatitis, Eczema, Rashes, Suppression of bone turnover."
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, AST increased, diarrhea, rash, ALT increased, Vitamin D deficiency, dyspnea, dizziness, oropharyngeal pain, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, portal vein thromboses, pain in extremity, portal vein thrombosis."
310,QUTENZA,all-concat,"application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
311,SAPHRIS,all-concat,"dementia-related psychosis, death, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, anaphylaxis, angioedema, Application site reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Cerebrovascular Adverse Events, stroke, transient ischemic attack, increased weight, extrapyramidal symptoms, dizziness, somnolence, akathisia, oral hypoesthesia, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, insomnia, anxiety, depression, vomiting, constipation, dry mouth, salivary hypersecretion, stomach discomfort, irritability, headache, hypertension, abdominal pain, nausea, vomiting, glossodynia, irritability, muscle strain, hyperinsulinemia, increased ALT, increased AST, dehydration, myalgia, tachycardia, oropharyngeal pain, nasal congestion, dyspnea, rash, dysmenorrhea, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, lactation, amenorrhea, gynecomastia, impotence, galactorrhea, breast cancer, dyspnea, wheezing, rash, peripheral edema, drug fever, primary central nervous system pathology, diabetic ketoacidosis, hyperosmolar coma, polydipsia, polyuria, polyphagia, weakness, dyskinesia, dystonia oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, parkinsonism, protrusion tongue, resting tremor, suicidal ideation, anger, bradycardia, respiratory, central nervous system depression, hyponatremia, hypokalemia, hypomagnesemia, gonadal steroidogenesis, hypogonadism, decreased bone density, aspiration pneumonia, myocardial infarction, unstable heart disease"
312,SIMPONI,all-concat,"serious infections, serious infections leading to hospitalization or death, infection, severe hepatic reactions, acute liver failure, liver enzyme elevations, autoimmune disorders, formation of autoantibodies, lupus-like syndrome, infusion reactions, infusion reaction, immunogenicity, antibodies to SIMPONI ARIA, upper respiratory tract infection, nasopharyngitis, pharyngitis, laryngitis, rhinitis, viral infections, influenza, herpes, bacterial infections, bronchitis, vascular disorders, hypertension, skin and subcutaneous disorders, rash, pyrexia, leukopenia, superficial fungal infection, sinusitis, abscess, lower respiratory tract infection, pneumonia, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin exfoliation, bullous skin reactions, death, tuberculosis (TB), bacterial sepsis, invasive fungal, histoplasmosis, opportunistic infections, Legionella, Listeria, lymphoma, other malignancies, heart failure, demyelinating disease, hepatitis B reactivation, congestive heart failure, multiple sclerosis, Guillain-Barre syndrome, optic neuritis, abatacept, anakinra, hematologic cytopenias, pancytopenia, aplastic anemia, thrombocytopenia, live vaccines, therapeutic infectious agents, BCG bladder instillation, hypersensitivity reactions, anaphylactic or other serious allergic reaction."
313,SIRTURO,all-concat,"increased mortality, death, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, ventricular arrhythmia, QTcF interval >500 ms, aminotransferase elevations, serum calcium below normal, serum magnesium below normal, serum potassium below normal, clinically significant ventricular arrhythmia, QTcF interval greater than 500 ms, fatigue, jaundice, dark urine, liver tenderness, hepatomegaly, ALT increase, AST increase, alkaline phosphatase increase, bilirubin increase, total bilirubin elevation greater than two times the upper limit of normal, syncope."
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, gastroenteritis viral, electrocardiogram abnormal, change in color vision, death (due to possibility of fatal events with adverse reactions such as Non-arteritic anterior ischemic optic neuropathy - NAION), decreased vision, loss of vision, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, hypotension, unstable angina, angina with sexual intercourse, congestive heart failure, priapism, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, symptomatic hypotension, fainting, bleeding disorders, active peptic ulceration, sexually transmitted diseases"
315,STRIBILD,all-concat,"lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, death, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, hyperpigmentation, laboratory abnormalities, proteinuria, serum creatinine increase, eGFR decrease, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, redistribution/accumulation of body fat, autoimmune disorders, immune reconstitution inflammatory syndrome (IRIS), Graves' disease, polymyositis, Guillain-Barre syndrome."
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, Pancreatitis, Hypersensitivity manifesting as bullous rash, Interstitial nephritis, Leukopenia, Lymphopenia, Neutropenia, Anemia, Thrombocytopenia, Increased alanine aminotransferase (ALT), Increased aspartate aminotransferase (AST), Increased gamma glutamyltransferase (GGT), Hyperbilirubinemia, Hypoalbuminemia, Increased alkaline phosphatase, Hyponatremia, Hypophosphatemia, Hypokalemia, Increased creatinine, Hypomagnesemia, Hyperkalemia, Hypercalcemia, Hypocalcemia, QT Prolongation, Retinal vein occlusion, Interstitial lung disease, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, vision blurred, transient blindness, stomatitis, asthenia, Cellulitis, folliculitis, paronychia, rash pustular, Skin papilloma, Palmar-plantar erythrodysesthesia syndrome, Hyperhidrosis, Hypertension, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, cuSCC, squamous cell carcinoma of the skin, non-cutaneous malignancies, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, syncope, back pain, muscle spasms, pain in extremity, dehydration, Insomnia, Hemorrhage, Urinary tract infection, Renal failure, death"
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Immunogenicity, Anti-albiglutide antibodies, Anti-GLP-1 antibodies, Anti-human albumin antibodies, Liver Enzyme Abnormalities, Alanine aminotransferase increase, Gamma Glutamyltransferase increase, Heart Rate Increase"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, death"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, Hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, completion, renal impairment, pruritus, elevated ALT, elevated AST, elevated creatine kinase, hyperglycemia, elevated lipase, elevated total neutrophils, elevated cholesterol, elevated HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, CLL, NHL, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypertensive crisis, hypersensitivity, febrile neutropenia, pneumonia, hypokalemia, dehydration, gastrointestinal disorders, diarrhea, abdominal pain, gastroesophageal reflux disease, abdominal distension, chills, edema peripheral, chest pain, pain, infection, herpes simplex, herpes zoster, sinusitis, urinary tract infection, oral candidiasis, nasopharyngitis, weight loss, hyperuricemia, high blood sugar, elevated creatinine levels, hyponatremia, hypocalcemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, depression, insomnia, anxiety, cough, dyspnea, wheezing, rash, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, anaphylactic and anaphylactoid reactions, hemolysis, dysgeusia, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, injection or infusion site including phlebitis, irritation, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), death."
323,TRULICITY,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal pain, Decreased Appetite, Dyspepsia, Fatigue, Gastrointestinal Adverse Reactions, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Systemic hypersensitivity, Injection-site reactions, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase and Lipase Increase, Medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), Macrovascular outcomes"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin and scalp irritation, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, neonatal gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis."
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, gout flare, cardiovascular thromboembolic events, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hepatic failure (death), jaundice, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, aggressive thoughts."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, embryofetal toxicity, death"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, acute exacerbation, respiratory compromise, fever, pyrexia, headache, chills, fatigue, anti-drug antibodies, immunogenicity, neutralizing antibodies, acute respiratory illness, acute respiratory complications, spine or cervical cord compression (SCC), back pain, paralysis, urinary incontinence, fecal incontinence, peripheral edema, death"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, image interpretation errors, radiation risk"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, death, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea (adverse reaction leading to dose reduction), vision disorders including visual impairment, photopsia, blurred vision, vitreous floaters, neuropathy, renal cysts, Hepatotoxicity (fatal), ILD/Pneumonitis, QT Interval Prolongation, Severe Visual Loss, Embryofetal Toxicity, visual disturbances, sensory neuropathy, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, ALT elevation, AST elevation, Hypophosphatemia, Neutropenia, Lymphopenia, Hypokalemia, muscle spasm, pyrexia, pain in extremity, weight increased, dizziness, headache, dyspepsia, dysphagia, abdominal pain, fatigue, rash, hepatic failure, syncope."
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal ulceration, ectropion, death"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, flexor tendon rupture of the treated finger, blood blister, injection site hematoma, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, anaphylaxis, allergic reactions (pruritus), ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis, risk of bleeding in patients with abnormal coagulation, death (added due to the mention of fatal events such as corporal rupture)."
334,XTANDI,all-concat,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, death"
335,YERVOY,all-concat,"Immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, immune-mediated adverse reactions, fatal immune-mediated adverse reactions, death, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), infusion-related reactions, hypersensitivity reactions, anaphylaxis, myositis, polymyositis, ocular myositis, Guillain-Barre syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis)."
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, death, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, hepatotoxicity, diarrhea/colitis, elevated transaminases, nausea, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, death"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, Diarrhea, Nausea, Elevated Transaminases, Vomiting, Abdominal Pain, Fatigue, Decreased Appetite, Constipation, Convulsion, Pneumonia, Dyspnea, Dehydration, Respiratory Failure, Pneumothorax, Gastric Hemorrhage, General Physical Health Deterioration, Pulmonary Tuberculosis, Cardiac Tamponade, Sepsis, Neuropathy, Vision Disorder, Vision Impairment, Blurred Vision, Photopsia, Accommodation Disorder, Presbyopia, Reduced Visual Acuity, Hemoglobin Decreased, Alanine Transaminase Increased, Aspartate Transaminase Increased, Creatinine Increased, Glucose Increased, Phosphate Decreased, Lipase Increased, Bilirubin Increased, death"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, sudden death, death"
